SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

YOUNG JOHN D

(Last)

(First)

(Middle)

PFIZER INC.-CORP. SECRETARY

235 EAST 42ND ST.

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2012

3. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Business Unit President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	66,539	D
Common Stock	1,215	I	By Trustee under the Pfizer Share Ownership Plan

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽¹⁾	02/21/2017	Common Stock	41,700	$25.87	D
Employee Stock Option (right to buy)	⁽¹⁾	02/22/2016	Common Stock	31,500	$26.2	D
Employee Stock Option (right to buy)	⁽¹⁾	02/23/2015	Common Stock	21,600	$26.2	D
Employee Stock Option (right to buy)	⁽¹⁾	02/26/2013	Common Stock	22,950	$29.33	D
Employee Stock Option (right to buy)	⁽¹⁾	02/25/2014	Common Stock	29,300	$37.15	D
Stock Appreciation Rights	02/26/2014⁽²⁾	02/26/2014⁽²⁾	Common Stock	39,677	$12.7	D
Stock Appreciation Rights	02/25/2015⁽²⁾	02/25/2015⁽²⁾	Common Stock	49,364	$17.69	D
Stock Appreciation Rights	12/31/2014⁽²⁾	12/31/2014⁽²⁾	Common Stock	26,767	$18.19	D
Stock Appreciation Rights	02/24/2016⁽²⁾	02/24/2016⁽²⁾	Common Stock	52,570	$18.9	D
Stock Appreciation Rights	02/24/2018⁽³⁾	02/24/2018⁽³⁾	Common Stock	43,520	$18.9	D
Stock Appreciation Rights	02/23/2017⁽²⁾	02/23/2017⁽²⁾	Common Stock	51,578	$21.03	D
Stock Appreciation Rights	02/23/2019⁽³⁾	02/23/2019⁽³⁾	Common Stock	43,724	$21.03	D
Stock Appreciation Rights	02/28/2013⁽²⁾	02/28/2013⁽²⁾	Common Stock	23,135	$22.55	D

Explanation of Responses:

1. These options are fully exercisable.

2. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

3. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Remarks:

poajy12.htm

	Lawrence A. Fox, by power of atty., for John D. Young	06/08/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.